Doosan Enerbility (034020) 2026 outlook for US investors: the small modular reactor (SMR) supply chain opportunity, Korean gas turbine export potential, nuclear renaissance policy tailwinds, and how to access this Korean energy equipment company from US markets.
Celltrion (068270) 2026 outlook for US investors: ZYMFENTRA subcutaneous infliximab US market penetration, PBM formulary dynamics, pipeline beyond the first wave, and how to access this Korean biosimilar leader through OTC markets or ETFs.
LG Chem (051910) after spinning off LG Energy Solution: how US investors can access the parent company, whether the NAC discount closes, petrochemical cycle bottom prospects, and the advanced materials segment's role as a structural growth driver in 2026.
Can Samsung Electronics (005930) reclaim its semiconductor throne in 2026? This analysis covers HBM3E/HBM4 competition with SK Hynix, foundry GAA yield recovery, DRAM/NAND price cycle positioning, and how US investors can access Samsung exposure through OTC ADRs or ETFs.